Agios Pharmaceuticals Inc (AGIO.O) Quote| Reuters.com
Edition:
United States

Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

44.27USD
24 Jun 2016
Change (% chg)

$-4.23 (-8.72%)
Prev Close
$48.50
Open
$45.76
Day's High
$47.28
Day's Low
$44.21
Volume
957,456
Avg. Vol
809,184
52-wk High
$120.96
52-wk Low
$33.50

AGIO.O

Chart for AGIO.O

About

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of orally available small molecule medicines for the treatment of cancer and rare genetic disorders (RGDs), which are a subset of orphan genetic metabolic diseases. Its cancer product candidates are AG-221 and... (more)

Overall

Beta: --
Market Cap(Mil.): $1,678.80
Shares Outstanding(Mil.): 37.92
Dividend: --
Yield (%): --

Financials

  AGIO.O Industry Sector
P/E (TTM): -- 38.82 34.11
EPS (TTM): -3.62 -- --
ROI: -34.47 -5.72 14.23
ROE: -35.82 -4.83 15.46

BRIEF-Agios Pharma reports initial data from phase 1 study of AG-519 in healthy volunteers

* Agios reports initial data from phase 1 study of ag-519 in healthy volunteers Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 09 2016

BRIEF-Agios Pharmaceuticals, Celgene establish new collaboration in metabolic immuno-oncology

* Agios and Celgene establish new collaboration in metabolic immuno-oncology and amend certain rights from 2010 agreement

May 17 2016

BRIEF-Agios sees 2016 ending cash position of more than $390 mln

* Expects 2016 ending cash position of more than $390 million

May 17 2016

BRIEF-Agios, Celgene Corp to defer selection process for allocating rights to certain discovery programs

* Co and Celgene Corp agreed to defer from April 14, 2016 to June 1, 2016 selection process for allocating rights to certain discovery programs

Apr 14 2016

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $33.97 -0.62
Novartis AG (NOVN.S) CHF75.75 -1.20
Roche Holding Ltd. (ROG.S) CHF241.00 -5.50
Roche Holding Ltd. (RO.S) CHF246.20 -3.30
Sanofi SA (SASY.PA) €69.37 -2.63
AstraZeneca plc (AZN.L) 4,031.50p +133.00
GlaxoSmithKline plc (GSK.L) 1,482.00p +53.00
Eli Lilly and Co (LLY.N) $74.33 +0.39
Shire PLC (SHP.L) 4,106.00p +58.00
Shire PLC (3159084.L) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.